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ABSTRACT 
The use of nanoparticles as formulation components of topical drug delivery systems for the 
skin has been widely investigated in the literature.  Because of the conflicting conclusions 
resulting from these studies concerning the ultimate disposition of the nanoparticles employed, 
the research presented in this paper has been designed to evaluate objectively the fate of such 
structures when administered to mammalian skin. Confocal microscopy images of skin exposed 
to nanoparticles have therefore been assessed by quantitative statistical analysis. Sebum on the 
skin surface was naturally fluorescent and clearly defined the outermost part of the cutaneous 
barrier. Fluorescent polystyrene nanoparticles applied in aqueous suspension could infiltrate 
only the stratum disjunctum, i.e., skin layers in the final stages of desquamation. This minimal 
uptake was independent of contact time (up to 16 hours) and of nanoparticle size tested (20-
200 nm). When skin barrier function was modestly compromised, the nanoparticles remained 
incapable of penetration beyond the most superficial layers, corresponding to a depth of 2-3 μm, 
of the stratum corneum (the outermost, 15-20 μm skin layer). Overall, these results 
demonstrate objectively and semi-quantitatively that nanoparticles contacting intact, and even 
partially damaged, skin cannot penetrate beyond the superficial layers of the barrier, and are 
highly unlikely, therefore, to reach the viable cells of the epidermis or beyond.  It follows that 
nanoparticulate-based, topical delivery systems may prove useful as skin surface reservoirs 
from which controlled drug release over time may be achieved. 
INTRODUCTION 
Nanotechnology is rapidly becoming integrated into many areas of manufacturing. Exposure to 
nano-scale objects either intentionally (through the use of cosmetics, for example, or via 
administration of topical, oral and injected medicines) or accidentally in the workplace (e.g., 
contact with coatings, dyes, composite materials, etc.) is therefore increasing. As a result, there 
is concern that these nanomaterials pose a greater health risk because their properties differ 
from those of the bulk substances [1]. For example a widely used "inert" compound, carbon 
black, in nanoparticulate form, appears to induce inflammatory signalling in lung cell cultures 
by generating reactive oxygen species [2]. Silica nanoparticles (<50 nm), on the other hand, do 
not have this effect but have been shown to damage keratinocytes whereas larger particles do 
not [3]. Since the toxicity of a material depends upon how easily it reaches the site of action, a 
detailed understanding of whether, and to what extent, nanoparticles are able to enter the body 
is vitally important.  Equally, the opportunities presented by “nanomedicine” have led to a very 
broad examination of the potential of nanoparticles as drug delivery vectors, including their use 
in topical formulations designed to treat skin disease, or to facilitate systemic access via the 
transdermal route [4,5].  Despite the obvious challenge presented by the skin to the ingress of 
even very small particulate materials, the debate continues as to how such nano-structures can 
improve cutaneous, or even systemic, bioavailability of associated drugs. 
The skin represents a major barrier to many environmental, chemical and biological assaults 
[6]. The outermost layer of the skin is the stratum corneum, a water-resistant “wall” of 
terminally-differentiated keratinocytes (called corneocytes) “riveted” together via 
corneodesmosomes [7] and damp-proofed by a “mortar” consisting of highly organized lipid 
lamellae. The skin is an excellent barrier to micro-organisms, macromolecules, and significantly 
retards the outward transport of water and the inward diffusion of small molecules. However, 
the evidence whether nanoparticles can infiltrate into underlying tissues is conflicting [4,5], and 
clarification of the issue is essential, not only for individuals with normal barrier function but 
also, more importantly, for those with compromised skin due to disease (e.g., eczema) or 
physical abrasion.  
Investigations employing transmission electron microscopy [8,9] and atomic spectroscopy 
[10,11] have suggested that inorganic zinc oxide and titanium dioxide nanoparticles do not 
penetrate the skin. Confocal laser scanning imaging has demonstrated that fluorescent 
polystyrene nanoparticles remain at the surface of the skin and appear to concentrate in and 
around hair follicles following a 2-hour exposure [12].  Multiphoton microscopy of 
fluorescently-labelled poly(lactide-co-glycolide) (PLGA) particles of ~300 nm diameter 
similarly showed that no penetration into/through the stratum corneum occurred [13]. 
However, dextran (1 μm) [14], iron (5 nm) [15], PLGA (1-10 μm) [16],  quantum dots [17], and 
silver (25 nm) [18] particles have been reported to penetrate the skin barrier (although it is 
possible that the apparent permeation of silver may have occurred after dissolution of the 
particles). Even if the apparent, extensive penetration of certain nanoparticles (e.g., PLGA) may 
have been caused by accidental transfer during mechanical skin tissue sectioning, the issue 
remains controversial and requires resolution; there continue to be claims that nanoparticles 
included in pharmaceutical and cosmetic formulations, for example, are able to improve “active” 
penetration, at least partly due to the ability of the vectors to transport into and even through 
the skin [16,19,20]. The uncertainty is reflected in the concerns of the regulatory authorities 
charged with ensuring the safety of new products containing nanoparticles and, in particular, 
determining the potential risk of systemic exposure both across normal, intact skin and through 
skin, the barrier function of which may be compromised. 
Confocal microscopy is an excellent technique for examining the internal, spatial disposition of 
fluorescent objects within the skin without need for physical sectioning. Since the skin does not 
require fixation or sectioning, artefacts associated with these techniques are prevented. 
Confocal microscopy, however, is unable to resolve individual nanoparticles; even with 
excellent optics, the diffraction limit for the resolution of green laser light is approximately 250 
nm (hence, while individual particles of approximately 300 nm diameter have been discerned 
[13], smaller nanoparticles (≤ 100 nm) would not have been resolvable even with multiphoton 
imaging). Nevertheless, even though individual particles cannot be resolved, the fluorescence 
signal from these nano-structures far surpasses the skin’s autofluorescence, which is not 
expected to change over the course of the experiments described here. Hence, any change in the 
pattern of the fluorescence signal must therefore be the result of translocation of the 
fluorophore.  
In this paper, a quantitative approach is proposed and applied to the assessment of fluorescent 
nanoparticle disposition (i.e., spatial distribution) within the skin. Despite the fact that this 
method cannot reveal detailed mechanistic information, it is well-suited to address the basic 
question: “to what extent and depth are nanoparticles able to penetrate the skin’s barrier?” The 
specific objective, therefore, was to undertake a quantitative analysis of the position of 
polymeric nanoparticles on the skin and to determine whether these structures penetrated the 
stratum corneum. The extent to which nanoparticle disposition was altered when stratum 
corneum integrity had been partially compromised was also considered.  
MATERIALS AND METHODS 
Materials 
The skin disposition of Fluospheres® (Invitrogen Ltd, UK), which are covalently carboxy-
modified, fluorescent, polystyrene particles with nominal diameters of 200, 100 and 20 nm, was 
assessed. Pig skin was obtained from a local abattoir, coarse hairs were trimmed and the tissue 
was dermatomed (Zimmer Electric Dermatome, Dover, Ohio, USA) to an approximate thickness 
of 750 µm. The skin was frozen and maintained at -20°C until required. Scotch book tape #845 
(3M Media, Germany) was used to strip off the outer layers of the skin to induce minor damage 
to its barrier function. Skin surface lipids were removed from specified samples by washing 
with cold hexane (HPLC grade, Fisher Scientific Corporation, Loughborough, UK). 
In vitro skin permeation 
Prior to an experiment, the skin was thawed and any remaining hairs were carefully trimmed as 
close as possible to the surface. The tissue was clamped between the donor and the receptor 
compartments of a vertical Franz diffusion cell (area = 0.8 cm2). The receptor compartment was 
carefully filled with warm phosphate-buffered saline (32°C, pH 7.4) allowing any bubbles to 
escape through the open port. A 100 μL aliquot of a 4.0 mg mL-1 aqueous suspension of 
Fluospheres®, or simply distilled water, was introduced into the donor chamber and sealed 
from the atmosphere using Parafilm®. The Franz cell was then placed in an oven at skin 
temperature (32°C) for the duration of the experiment. At the end of the exposure, the Franz cell 
was disassembled and excess surface liquid was gently absorbed with tissue. The centre of the 
sample was excised and placed on a slide for confocal microscopy. A drop of propylene glycol 
was placed on the sample immediately before imaging to minimize refractive index artefacts 
caused by potential air gaps under the coverslip.  
At least four pieces of skin were exposed to aqueous suspensions of 200, 100 and 20 nm 
Fluospheres®, or to water alone. Samples were incubated for a range of times between 5 
minutes and 16 hours.   A control experiment involving application of a simple fluorescein 
solution in water was not performed, as the charged fluorophore does not penetrate into the 
skin to any measurable extent. 
Subsequently, the experiments were repeated with skin, the barrier function of which had been 
partially compromised by removal of 4 tape-strips immediately prior to mounting in the Franz 
cell. Each tape was pressed firmly onto the skin sample and then removed in a single smooth 
movement. The direction of successive tape-strips was changed by 90° to improve the evenness 
of the process. 
Sebum Removal 
A skin sample was divided in two halves, one of which served as a control and was gently 
washed five times with 5 mL of water. The other piece was gently washed five times, with 5 mL 
of cold hexane (~4°C). Both samples were examined immediately post-washing using laser 
scanning confocal microscopy. 
Laser scanning confocal microscopy 
Images were obtained using a 510 Meta inverted confocal laser scanning microscope (Carl Zeiss, 
Jena, Germany). Samples were excited sequentially using 405 nm (diode), 488 nm (argon) and 
633 nm (HeNe) lasers. A Plan-Apochromat 63×/1.40 oil DIC M27 objective was used for 
acquisition of all images. Fluorescence signals were recorded as three discrete channels at 420-
480 nm (blue), 505-530 nm (green) and 647-754 nm (red), respectively. 
Regions of interest were selected as coordinates from a 28×28 grid of 143×143 μm2 fields of 
view using true random numbers generated using the internet-available resource: 
"Random.org" [21]. Each image stack recorded was 10-60 μm deep. Since the skin was not 
squashed flat by the coverslip, some fields of view selected showed a sloping skin surface across 
the image. The deeper stacks were recorded, therefore, to allow the entire image region to be 
analysed, without the need for subjective preference for flatter parts of the skin. Images in the z-
direction were collected every micrometre. At least three random regions of interest were 
recorded for each skin sample. Randomly allocating these areas within the sample prevented 
selection bias of those offering the most attractive images. Furthermore, the entire image 
acquired was subjected to the analysis described below; i.e., all of the information collected was 
used to assess the behaviour under examination. 
Image integration was performed at least twice for all samples to smooth noise from the 
photodiode detector. For the control samples, not treated with nanoparticles, the excitation 
intensity and gain were increased, and images were integrated at least four times to facilitate 
detection of autofluorescence and to smooth background noise. 
Figure 1 shows five of the twenty x-y slices (at 0, 2, 4, 8 and 18 μm) from a typical z-stack, 
recorded from 0 to 19 μm through a region of interest. Areas, which are black, contained no 
measurable fluorescence. Red and blue areas represent autofluorescence from the skin, while 
green areas correspond to the presence of Fluospheres®. When combined, these images create a 
3-dimensional fluorescence map of the sample as illustrated in Supplementary Data 1.  Images 
were saved as 512×512 pixel.lsm files (a Zeiss proprietary format). Each file consisted of a 
hyperstack of three superimposed channels, where each channel comprised a stack of images of 
one colour recorded as a function of depth through the skin. 
Subsequently, the red and blue channels of each image were merged and the resulting red/blue 
and green image stacks were converted to 128×128 pixel text image sequences using ImageJ 
[22]. Reducing the image size smoothes each pixel by a further 16-fold, thereby improving the 
signal-to-noise ratio at the cost of reducing the resolution. 
 
Figure 1: Fluorescence images of the distribution of 200 nm Fluospheres® on pig skin after a 16-
hour exposure. Images were collected in the x-y plane from above the skin surface (0 μm) and then 
every 1 μm into the sample in the z-direction until green fluorescence was no longer visible. Five 
panels illustrate the results observed at different depths (2, 4, 8 and 18 μm) from the skin surface 
(0 μm). The last panel is a composite stack of all images recorded at each 1 μm step through the 
sample. The complete stack was rendered using the ImageJ 3D Viewer plugin. Scale bars are 20 
μm.  A 3-D reconstruction and animation of the stack is in Supplementary Data 1. 
Image Analysis 
The text images (i.e., data arrays containing the signal values for each pixel of each image) were 
analysed using the R statistical software package [23]. The autofluorescence signal (v) from the 
mixed red/blue channel can be examined to characterise the region corresponding to the skin 
within the image stack (as a function of depth, z). The edge of the skin was estimated using the 
midpoint parameter (T) of a sigmoid function [24]. 
  TzA S
A
Bv



exp1
 (1) 
where A is the amplitude, BA is the background signal when no skin is present, and S is the 
sharpness of the edge. Note that the signal does not return to zero when an image is taken 
outside the skin because of an offset in the minimal signal recorded. The majority of this signal 
is caused by extraneous scattered light striking the detector. The skin signal profile does not 
have a sharp edge since the volume that the microscope illuminates is finite; variations in the 
exact positions of the skin surface, varying concentrations of fluorescent compounds, and other 
sources of noise, cause smoothing of the profile. The fluorescence signal attenuates through the 
skin as the exciting and emitted beams are progressively absorbed and scattered with 
increasing path length. 
 
Figure 2: Sigmoid function (solid line) used to estimate location of the outer skin edge through a 
36×36 μm2 quadrant from a typical region of interest. The data points represent the mean values, 
the light blue area shows the range of the data, while the darker blue region indicates the first to 
ninth deciles.  
Figure 2 illustrates how the autofluorescence signal varies in a sampling region with depth 
through the z-stack. For many images, this function can be used to estimate the outer edge of 
the skin. However, the sigmoid function was not robust for images where the signal decayed 
below the surface of the skin. In these cases, the edge was found by truncating the image to 
exclude the deeper skin where the signal had begun to fall off. Any missing values were 
estimated by comparing the successfully calculated values from Equation (1) with the position 
of the autofluorescence signal (v) maximum near the skin surface. The position in the image 
stack (z) of the outer edge of the skin was estimated using Equation (2): 
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which describes a normal distribution where FA is an area parameter, MA is the midpoint 
parameter (determined at the peak of the autofluorescence signal), and WA is the peak width 
parameter.  
The position of the edge, T, was then subtracted from the distance (z) through the image to 
calculate the depth (d) into the skin of the green channel signal intensity (u) in each of sixteen 
36×36 μm2 quadrants. Sources of error in this approach include uncertainty in the precise 
location of the skin surface, variability in the brightness of the autofluorescence signal, and 
differences in the disposition of particles across each skin sample. The distribution of particles 
was defined within a bounded region of the skin. The profile of the green channel signal across 
the skin was deduced by inspection to be log-normal, and conformed, therefore, to the 
relationship: 
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where MS and WS are the mean and standard deviation (in log units) of the log-normal 
distribution [25]. So that the distribution could be fitted directly to the data, the signal intensity 
was modelled using two additional parameters such that: 
 dfFBu SS   (4) 
where BS represents a background correction factor and FS is an expansion factor. 
Figure 3 shows the sum of the green fluorescence signals (u) in each quadrant of a region of 
interest through the sample (d). The median position of a log-normal distribution is the 
exponential of the peak position, MS. The latter was calculated from the parameters of the fit for 
each quadrant. To determine whether the Fluospheres® moved into the skin with increasing 
duration of contact, these median peak positions were compared over time. For some images, 
the signal-to-noise ratio of the fluorescence was too low to determine the profile. Also, 
occasionally, when the skin surface in the region of interest was very uneven, the model was not 
always able to converge on a solution. 
For each randomly chosen area on each skin sample, a profile of the green signal distribution 
was generated with very few human decisions required, thereby reducing the subjectivity 
inherent in image interpretation and improving reliability. In this way, the derived parameters 
describing the profiles can be compared across images to assess whether the nanoparticles, 
which are too small to resolve optically, were actually penetrating beyond the skin surface or 
not.  Emphasis should not be placed on the absolute signal intensities, as the gain was adjusted 
to maximise the dynamic range of data collection from each image.  No pixels recorded a signal 
of zero, and the lowest values were typically ~20 (Figure 2). Each quadrant contained 1024 
pixels and, since each image was recorded at a fixed scale, background subtraction and 
normalization were not required. The parameters shown on Equation (4) were used instead, 
with BS ≈ 14000.  Because the total signal from each image is the sum of autofluorescence and 
that from the Fluospheres, and as both signals can vary between images, the absolute signal 
intensities cannot be reliably interpreted. However, signal distribution would vary if there were 
penetration of nanoparticles. Hence, when using the log-normal distribution as described, the 
position of peak fluorescence is the best description of particle penetration.  
 
Figure 3: Distribution of green signal intensity (u) in one 143×143 μm2 region of skin following 
application of 200 nm Fluospheres® for 16 hr. A log-normal distribution (Equation (3)) was fitted 
to the data for each of sixteen 36×36 μm2 quadrants using non-linear mixed effects modelling with 
R software. Dashed lines show the population mean profile; solid lines show the local mean for 
each quadrant. 
  
RESULTS AND DISCUSSION 
The blue fluorescent layer observed at the surface of untreated (control) pig skin corresponds 
to excitation with the diode laser at 405 nm (Figure 4, panels a-d). The most likely origin of 
this signal is sebum which has been shown to fluoresce when excited with UV light [26]. 
Confirmation of this idea is reflected in the variable intensity of the blue fluorescence seen in 
the images obtained and, in particular, by the maxima found in the region of hair follicles, via 
which sebum is secreted from the pilosebaceous glands (see TOC graphic for an example).  
Figure 4: Cross-sections through four pieces of pig skin derived from confocal microscopy stacks 
of serial x-y images. Each skin piece was divided in half and examined either “as is” (panels a-d) or 
post-washing with cold hexane (panels e-h). The dotted line indicates the approximate position of 
the skin surface.  
Sebum is composed of a mixture of lipids (triglycerides, wax esters, squalene and small amounts 
of cholesterol esters). When it emerges onto the skin surface, it mixes with the lipids of the 
stratum corneum to form a superficial lipid film [27]. Washing skin with cold hexane has been 
shown to remove skin surface lipids without affecting skin barrier function i.e. without altering 
transepidermal water loss [28]. This treatment decreased considerably the intensity of the blue 
fluorescent layer compared to the control (Figure 4, panels e-h); in some cases, post-washing 
with hexane, only the red autofluorescence from deeper skin layers remained. The results are 
fully consistent with an earlier investigation using infrared spectroscopy, which revealed a 
significant presence of sebaceous lipids in the outer layers of human stratum corneum in vivo 
[29]. 
Fluospheres® were visible in the top layers of the stratum corneum after a short 5 minute 
contact with intact skin. However, no further penetration appeared to take place over the next 
16 h. Figure 5 shows typical cross-sections through the skin as converted from confocal 
microscopy stacks of serial x-y images. Although the laser power and gain were increased for 
blank samples, the intensity of the green signal was rather low compared to images of 
(e) 
(f) 
(g) 
(h) 
(a) 
(b) 
(c) 
(d) 
Fluospheres®.  Random speckle throughout the green channel indicates where the gain had 
been increased due to a lack of strongly fluorescing regions.  Supplementary data 2, 3, and 4 
contain animated scans (from which the images in Figure 5 were extracted) across the skin 
samples examined post-treatment with the fluorescent nanoparticles of different diameters, 
while Supplementary data 5 presents the control, untreated results.  The fluorescence 
densities from the different size nanoparticles were similar from sample to sample and were not 
correlated with the calculated fluorescein equivalents per nanoparticle volume (which varied by 
about 3-fold between the different particle diameters employed).  In any case, as the objective of 
the experiments was to examine fluorescence distribution, rather than absolute intensity, it was 
not necessary to control precisely the total fluorescence applied to the skin. 
 
Figure 5: Confocal microscopy cross-sections of the upper layers of pig skin following a 5-minute 
application of 200 nm (a,b), 100 nm (c,d), and 20 nm Fluospheres® (e,f), and water (g,h). Panels a, 
c, e and g are images post-administration to intact skin, whereas panels b, d, f and h show 
representative results following delivery to tape-stripped skin. The horizontal red line in some 
images was caused by reflection from the coverslip interface when the channel gain was 
increased.  See also Supplementary data 2-5. 
Figure 6 shows the estimated depth of the green fluorescent signal peak in the stratum 
corneum after exposure of the skin to Fluospheres® of different diameters or to water alone (the 
‘blank’ experiments). The duration of contact between the formulations and the skin did not 
alter the results in any perceptible fashion.  No particle aggregation was observed in the 
suspensions prior to their application to the skin, although the possibility that aggregation may 
have occurred once the nanoparticles made contact with the skin surface cannot be ruled out. 
The fact that particles were observed at apparent depths of 2-3 μm probably corresponds to 
their infiltration into/through the stratum disjunctum, the most superficial layer of the stratum 
corneum consisting of loosely associated and desquamating corneocytes [30]. The similar 
disposition seen in tape-stripped skin may reflect a small mechanical perturbation of the barrier 
provoked by removal of the adhesive. 
 
Figure 6: Position of peak fluorescence/autofluorescence for particles and blank samples. Error 
bars show standard deviation. There were no differences between samples observed at different 
exposure times. Peak signal was observed at a greater depth in intact skin than in stripped skin. 
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 Figure 7: Spatial distribution of fluorescent nanoparticles of different diameters as a function of 
time of exposure to the skin (both intact and tape-stripped – upper six panels). The lower two 
panels show the distribution of skin autofluorescence in intact and tape-stripped samples. 
 
These conclusions are reinforced by the data in Figure 7, which illustrates the evolution over 
time of the spatial distributions of the 200, 100 and 20 nm fluorescent particles within the 
stratum corneum of intact and tape-stripped skin. The figure also shows that the pattern of 
green autofluorescence from untreated (intact and tape-stripped) skin does not change with 
time, confirming that there is no significant redistribution of the faintly fluorescent endogenous 
species during the experiment.   
Figure 7 demonstrates clearly that there was no time-dependent penetration of any of the 
Fluospheres® examined. The apparent distribution profile of the particles appears from the 
boxplots to be slightly wider in intact skin than in tape-stripped skin. As suggested above, this 
would be consistent with particles infiltrating with little resistance into and through the 
desquamating layer of the stratum corneum (see the left-hand panels in Figure 5). This 
hypothesis is supported by the fact that this disposition occurs within the first 5 minutes of skin 
contact but that, thereafter, negligible change in the profile occurs over the next 16 hours (and 
further evidence may be visualised clearly in the animated scans in Supplementary data 2-5). 
It should be emphasised that this research has clearly not been able to make a systematic 
evaluation of nanoparticle disposition on the skin for the entire spectrum of particle properties, 
including shape and charge (although some results with respect to the latter parameter have 
been reported [31]).  The impact of such other important variables remains to be determined.  
Further, while the conclusions to be drawn from the data presented here are somewhat 
unequivocal, the observations and their analysis cannot explain, with any degree of certainty, 
why others have reported nanoparticle uptake into living skin layers following their topical 
application (e.g., [15,17]). While speculative alternatives might be proposed, such as accidental 
contamination on sectioning, or invisible flaws in skin integrity (across which, for example, a 
very small quantum dot of a few nanometres diameter might be able to travel), complete 
understanding will only be possible with further, scrupulously controlled experiments coupled 
with objective data analysis and interpretation.  Finally, although a number of previous 
publications have pointed out the sequestration of nanoparticles in and around follicular 
structures [11,12,32], this behaviour (which can be observed in the animated scan in 
Supplementary data 4, for example) has been overly emphasised here because of the reported 
contraction of follicles that occurs when mammalian skin is dermatomed [33].  
Thus, the method described in this paper represents an objective evaluation of nanoparticle 
disposition post-application to the skin. The strategy used takes into consideration the 
potentially confounding effects of autofluorescence, and the statistical approach to data analysis 
reduces substantially the uncertainty associated with sample-to-sample variability, random 
imperfections in skin barrier function (resulting, for example, from tissue handling), 
fluctuations in laser performance, etc. Confocal imaging, which avoids mechanical sectioning of 
the tissue under examination, also allows the impact of a convoluted skin surface (that might 
give rise to an apparent “deep” penetration of particles as they are deposited into a fold or an 
invagination of the sample) to be visualised unambiguously and interpreted accordingly. The 
quantitative findings reported here support the more qualitative imaging data that has been 
previously described [12, 29], and which points persuasively to the efficient manner in which 
the stratum corneum excludes the ingress of particulate nanomaterials beyond the most 
superficial part of the barrier. 
 
CONCLUSIONS 
Polymeric nanoparticles (ranging in diameter from 20 to 200 nm) were observed to penetrate 
only into the surface layers (approximate depth of 2-3 μm) of the stratum corneum. This is 
interpreted as infiltration along fissures in the stratum disjunctum. Using quantitative analysis 
of bulk particle location, no time-dependent penetration of nanoparticles was observed, even 
when the barrier was partially compromised by adhesive tape-stripping.  It follows that such 
particles, when appropriately formulated, may prove useful as drug reservoirs which remain on 
or near to the skin surface and from which controlled release may be sustained over extended 
periods of time. 
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 FIGURE LEGENDS 
Figure 1: Fluorescence images of the distribution of 200 nm Fluospheres® on pig skin after a 
16-hour exposure. Images were collected in the x-y plane from above the skin surface (0 μm) 
and then every 1 μm into the sample in the z-direction until green fluorescence was no longer 
visible. Five panels illustrate the results observed at different depths (2, 4, 8 and 18 μm) from 
the skin surface (0 μm). The last panel is a composite stack of all images recorded at each 1 μm 
step through the sample. The complete stack was rendered using the ImageJ 3D Viewer plugin. 
Scale bars are 20 μm.  A 3-D reconstruction and animation of the stack is in Supplementary Data 
1. 
Figure 2: Sigmoid function (solid line) used to estimate location of the outer skin edge through 
a 36×36 μm2 quadrant from a typical region of interest. The data points represent the mean 
values, the light blue area shows the range of the data, while the darker blue region indicates 
the first to ninth deciles.  
Figure 3: Distribution of green signal intensity (u) in one 143×143 μm2 region of skin following 
application of 200 nm Fluospheres® for 16 hr. A log-normal distribution (Equation (3)) was 
fitted to the data for each of sixteen 36×36 μm2 quadrants using non-linear mixed effects 
modelling with R software. Dashed lines show the population mean profile; solid lines show the 
local mean for each quadrant. 
Figure 4: Cross-sections through four pieces of pig skin derived from confocal microscopy 
stacks of serial x-y images. Each skin piece was divided in half and examined either “as is” 
(panels a-d) or post-washing with cold hexane (panels e-h). The dotted line indicates the 
approximate position of the skin surface. 
Figure 5: Confocal microscopy cross-sections of the upper layers of pig skin following a 5-
minute application of 200 nm (a,b), 100 nm (c,d), and 20 nm Fluospheres® (e,f), and water (g,h). 
Panels a, c, e and g are images post-administration to intact skin, whereas panels b, d, f and h 
show representative results following delivery to tape-stripped skin. The horizontal red line in 
some images was caused by reflection from the coverslip interface when the channel gain was 
increased.  See also Supplementary data 2-5. 
Figure 6: Position of peak fluorescence/autofluorescence for particles and blank samples. Error 
bars show standard deviation. There were no differences between samples observed at 
different exposure times. Peak signal was observed at a greater depth in intact skin than in 
stripped skin. 
Figure 7: Spatial distribution of fluorescent nanoparticles of different diameters as a function of 
time of exposure to the skin (both intact and tape-stripped – upper six panels). The lower two 
panels show the distribution of skin autofluorescence in intact and tape-stripped samples. 
 
 
SUPPLEMENTARY FILES 
1. A 3-D reconstruction and animation of the composite stack of all images in the final (bottom 
right-hand) panel of Figure 1.  
2. Animated scan (from which the images in panels a and b of Figure 5 were extracted) across 
the skin samples examined post-treatment with 200 nm diameter fluorescent 
nanoparticles.  of different diameters, while Supplementary data 5 presents the control, 
untreated results. 
3. Animated scan (from which the images in panels c and d of Figure 5 were extracted) across 
the skin samples examined post-treatment with 100 nm diameter fluorescent 
nanoparticles.   
4. Animated scan (from which the images in panels e and f of Figure 5 were extracted) across 
the skin samples examined post-treatment with 20 nm diameter fluorescent nanoparticles.   
5. Animated scan (from which the images in panels g and h of Figure 5 were extracted) across 
the skin samples examined post-treatment with water alone (i.e., the control).   
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